drugset

drugset / Trial / NCT01805687

Single Dose Bronchodilatory Study in Asthma

NCT01805687 ↗

Phase 4 Completed 25 enrolled Cornerstone Therapeutics Inc.

NaSingle-groupOpen-labelTreatment

Summary

Study to evaluate the bronchodilator effects of Zyflo CR in patients with chronic stable asthma.

Timeline

Start: 2013-03
Primary completion: 2013-06
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Zileuton	Small molecule	1200 mg	Oral

Indications